Last update 25 May 2025

Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms
Ex vivo expanded allogeneic dT cells, Ex vivo expanded allogeneic T cells Beijing GD Initiative Cell Therapy Technology
Target-
Action-
Mechanism
Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsDigestive System DisordersEye Diseases+ [2]
Active Indication
Hepatocellular CarcinomaMetastatic melanomaUveal Melanoma
Inactive Indication-
Originator Organization
Beijing Jiadehe Cell Therapy Technology Co., Ltd
Active Organization
Beijing Jiadehe Cell Therapy Technology Co., LtdChinese Academy of Medical SciencesChinese Academy of Medical Sciences
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)
NCT06364800
/ Not yet recruitingEarly Phase 1IIT
The Safety and Efficacy Assessment of Allogeneic γδ T Cells Combined With Targeted Therapy and Immunotherapy in Hepatocellular Carcinoma Patients
NCT06364787
/ Not yet recruitingPhase 1IIT
The Safety and Efficacy Assessment of Allogeneic γδ T Cells Combined With Targeted Therapy and Immunotherapy in Hepatocellular Carcinoma Patients
NCT06212388
/ Not yet recruitingEarly Phase 1IIT
Efficacy and Safety of Allogeneic γδ T Cells (γδ T Cells) Combined With Interferon-alpha1b (IFN-α1b) or PD-1 Monoclonal Antibody in Neoadjuvant Treatment of Stage III-IV Resectable Melanoma
100 Clinical Results associated with Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)
Login to view more data
100 Translational Medicine associated with Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)
Login to view more data
100 Patents (Medical) associated with Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)
Login to view more data
100 Deals associated with Allogenic gamma delta T cell therapy (Beijing GD Initiative Cell Therapy Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 1-
Beijing Jiadehe Cell Therapy Technology Co., Ltd
24 Jan 2024
Uveal MelanomaPhase 1-
Beijing Jiadehe Cell Therapy Technology Co., Ltd
24 Jan 2024
Hepatocellular CarcinomaPhase 1
China
Beijing Jiadehe Cell Therapy Technology Co., Ltd
15 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free